These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1842413)

  • 21. [Myocardial cellular damage and the activity of the mitochondrial ATP synthase in rats infected with a Colombian strain of Trypanosoma cruzi].
    Rendón DA; Genes CM; Triana O
    Biomedica; 2007 Jan; 27 Suppl 1():40-9. PubMed ID: 18154244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of nitric oxide in the development of cardiac lesions during the acute phase of experimental infection by Trypanosoma cruzi].
    Borges CR; Rodrigues Junior V; dos Reis MA; Castellano LR; Chica JE; Pereira SA; Santos ES; Rodrigues DB
    Rev Soc Bras Med Trop; 2009; 42(2):170-4. PubMed ID: 19448936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes.
    Toledo MJ; Bahia MT; Veloso VM; Carneiro CM; Machado-Coelho GL; Alves CF; Martins HR; Cruz RE; Tafuri WL; Lana M
    J Antimicrob Chemother; 2004 Jun; 53(6):1045-53. PubMed ID: 15102747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
    Bustamante JM; Presti MS; Rivarola HW; Fernández AR; Enders JE; Fretes RE; Paglini-Oliva P
    Int J Antimicrob Agents; 2007 Jun; 29(6):733-7. PubMed ID: 17395432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi.
    Horta AL; Figueiredo VP; Leite ALJ; Costa GP; Menezes APJ; Ramos CO; Pedrosa TCF; Bezerra FS; Vieira PMA; Talvani A
    Mem Inst Oswaldo Cruz; 2018 Oct; 113(11):e180271. PubMed ID: 30365644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and production of cardiac angiogenic mediators depend on the Trypanosoma cruzi-genetic population in experimental C57BL/6 mice infection.
    Shrestha D; Bajracharya B; Paula-Costa G; Salles BC; Leite AL; Menezes AP; Souza DM; Oliveira LA; Talvani A
    Microvasc Res; 2017 Mar; 110():56-63. PubMed ID: 27956355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous osteopontin induces myocardial CCL5 and MMP-2 activation that contributes to inflammation and cardiac remodeling in a mouse model of chronic Chagas heart disease.
    Caballero EP; Santamaría MH; Corral RS
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):11-23. PubMed ID: 28987763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole.
    Caldas IS; da Matta Guedes PM; dos Santos FM; de Figueiredo Diniz L; Martins TA; da Silva do Nascimento AF; Azevedo MA; de Lima WG; Neto RM; Torres RM; Talvani A; Bahia MT
    Trop Med Int Health; 2013 Jan; 18(1):75-84. PubMed ID: 23107306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.
    Silva RR; Shrestha-Bajracharya D; Almeida-Leite CM; Leite R; Bahia MT; Talvani A
    Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):513-21. PubMed ID: 22666863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.
    Ferreira RR; Abreu RDS; Vilar-Pereira G; Degrave W; Meuser-Batista M; Ferreira NVC; da Cruz Moreira O; da Silva Gomes NL; Mello de Souza E; Ramos IP; Bailly S; Feige JJ; Lannes-Vieira J; de Araújo-Jorge TC; Waghabi MC
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007602. PubMed ID: 31365537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation on the possibility of spontaneous cure of mice infected with different strains of Trypanosoma cruzi.
    Magalhães JB; Andrade SG
    Rev Inst Med Trop Sao Paulo; 1994; 36(6):481-4. PubMed ID: 7569619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains.
    Andrade SG; Rassi A; Magalhaes JB; Ferriolli Filho F; Luquetti AO
    Trans R Soc Trop Med Hyg; 1992; 86(6):624-6. PubMed ID: 1287919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
    Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
    Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
    Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins.
    Coelho LL; Pereira IR; Pereira MCS; Mesquita L; Lannes-Vieira J; Adesse D; Garzoni LR
    Parasit Vectors; 2018 Jan; 11(1):72. PubMed ID: 29382361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoramidon treatment improves the consequences of chagasic heart disease in mice.
    Jelicks LA; Chandra M; Shtutin V; Petkova SB; Tang B; Christ GJ; Factor SM; Wittner M; Huang H; Douglas SA; Weiss LM; Orleans-Juste PD; Shirani J; Tanowitz HB
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():267S-271S. PubMed ID: 12193101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A quantitative analysis of the mastocytes and eosinophilic granulocytes in the myocardium of Wistar rats chronically infected by Trypanosoma cruzi. A contribution to the knowledge of myocardial fibrosis].
    Pinheiro MC; Beraldo PS; Junqueira Júnior LF; Lopes ER; Chapadeiro E
    Rev Soc Bras Med Trop; 1992; 25(1):45-50. PubMed ID: 1308065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.
    Medeiros GA; Silvério JC; Marino AP; Roffê E; Vieira V; Kroll-Palhares K; Carvalho CE; Silva AA; Teixeira MM; Lannes-Vieira J
    Microbes Infect; 2009 Feb; 11(2):264-73. PubMed ID: 19100857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.